REQUEST A DEMO
Total
USD $0.00
Search more companies

Carewin Pharmaceuticals (Gujarat) Private Limited (India)

Main Activities: Sales Financing
Full name: Carewin Pharmaceuticals (Gujarat) Private Limited Profile Updated: April 02, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Carewin Pharmaceuticals (Gujarat) Private Limited is a company based in India, with its head office in Ahmedabad. The company operates in the Sales Financing industry. It was established on July 17, 1995. The latest financial highlights indicate a net sales revenue increase of 12.98% in 2025. During that time, Carewin Pharmaceuticals (Gujarat) Private Limited’s total assets grew by 17.64%. Carewin Pharmaceuticals (Gujarat) Private Limited’s net profit margin increased by 0.42% in 2025.

Legal Address
38, Saket Industrial Estate-2, Sarkhej-Bavla Road P.O. Moraiya, Sanand, Dist. Ahmedabad
Ahmedabad; Gujarat; Postal Code: 382210

Contact Details: Purchase the Carewin Pharmaceuticals (Gujarat) Private Limited report to view the information.

Basic Information
Registered Capital:
Purchase the Carewin Pharmaceuticals (Gujarat) Private Limited report to view the information.
Financial Auditors:
Purchase the Carewin Pharmaceuticals (Gujarat) Private Limited report to view the information.
Incorporation Date:
July 17, 1995
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after Carewin Pharmaceuticals (Gujarat) Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
12.98%
Total Operating Revenue
12.99%
Operating Profit
27.9%
EBITDA
14.63%
Net Profit/Loss for the Period
38.62%
Total Assets
17.64%
Total Equity
13.42%
Operating Profit Margin
0.46%
Net Profit Margin
0.42%
Return on Equity (ROE)
2.15%
Debt / Equity
3.11%
Quick Ratio
-0.04%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?